Select Biomarkers on the Day of Anterior Cruciate Ligament Reconstruction Predict Poor Patient-Reported Outcomes at 2-Year Follow-Up: A Pilot Study.

Christian LattermannCaitlin E-W ConleyDarren L JohnsonEmily K ReinkeLaura J HustonJanet L HuebnerChing-Heng ChouVirginia B KrausKurt P SpindlerCale A Jacobs

Published in: BioMed research international (2018)

These pilot data suggest that initial biochemical changes after injury may be an indicator of poor outcomes that are not mitigated by surgical stabilization alone. Biological adjuvant treatment in addition to ACL reconstruction may be beneficial; however, these data should be used for hypothesis generation and more definitive randomized clinical trials are necessary.

Keyphrases

patient reported outcomes
anterior cruciate ligament reconstruction
electronic health record
big data
early stage
clinical trial
squamous cell carcinoma
metabolic syndrome
randomized controlled trial
type diabetes
machine learning
locally advanced
weight loss
smoking cessation